Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: consensus group recommendations from the German-speaking countries
Hepatorenal tyrosinaemia (HT1) is an autosomal recessive disorder of tyrosine degradation resulting in hepatic and renal dysfunction, neurological sequelae may occur in some patients. The use of nitisinone (NTBC) has revolutionised treatment and outcome of this disorder. NTBC has to be combined with...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 2025
|
| In: |
Journal of inherited metabolic disease
Year: 2025, Jahrgang: 48, Heft: 1, Pages: 1-18 |
| ISSN: | 1573-2665 |
| DOI: | 10.1002/jimd.12824 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/jimd.12824 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12824 
|
| Verfasserangaben: | Anibh M. Das, Diana Ballhausen, Dorothea Haas, Johannes Häberle, Tobias Hagedorn, Cecilia Janson-Mutsaerts, Nils Janzen, Johannes Sander, Peter Freisinger, Daniela Karall, Uta Meyer, Eberhard Mönch, Susanne Morlot, Stefanie Rosenbaum-Fabian, Sabine Scholl-Bürgi, Stephan vom Dahl, Natalie Weinhold, Jiri Zeman, Karin Lange |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1927850622 | ||
| 003 | DE-627 | ||
| 005 | 20250710230843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250610s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jimd.12824 |2 doi | |
| 035 | |a (DE-627)1927850622 | ||
| 035 | |a (DE-599)KXP1927850622 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Das, Anibh Martin |d 1961- |e VerfasserIn |0 (DE-588)134237102 |0 (DE-627)563734981 |0 (DE-576)300395051 |4 aut | |
| 245 | 1 | 0 | |a Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1 |b consensus group recommendations from the German-speaking countries |c Anibh M. Das, Diana Ballhausen, Dorothea Haas, Johannes Häberle, Tobias Hagedorn, Cecilia Janson-Mutsaerts, Nils Janzen, Johannes Sander, Peter Freisinger, Daniela Karall, Uta Meyer, Eberhard Mönch, Susanne Morlot, Stefanie Rosenbaum-Fabian, Sabine Scholl-Bürgi, Stephan vom Dahl, Natalie Weinhold, Jiri Zeman, Karin Lange |
| 246 | 3 | 3 | |a Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type one |
| 264 | 1 | |c January 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 15. Dezember 2024 | ||
| 500 | |a Gesehen am 10.06.2025 | ||
| 520 | |a Hepatorenal tyrosinaemia (HT1) is an autosomal recessive disorder of tyrosine degradation resulting in hepatic and renal dysfunction, neurological sequelae may occur in some patients. The use of nitisinone (NTBC) has revolutionised treatment and outcome of this disorder. NTBC has to be combined with a low protein diet. While NTBC modulates the disease course in HT1 patients, several issues are open. Optimal dosage, doses per day, therapeutic range of NTBC concentration, mode of protein restriction and biomarkers are not well defined. HCC and neurocognitive deficits are long-term sequelae. Early diagnosis and treatment are essential to minimise the risk for these complications. Clinical guidance for management of HT1-patients is required. Randomised clinical studies are difficult in the presence of therapeutic options. We discussed these issues in a consensus group of 10 paediatricians, 1 adult hepatologist, 1 geneticist, 2 dieticians, 2 newborn screening specialists with experience in HT1, 1 psychologist and 2 representatives of a patient group from the German-speaking countries (DACH). Recommendations were based on scientific literature and expert opinion, also taking into account recent experience with newborn screening. There was strong consensus that newborn screening using succinylacetone (SA) and early treatment are essential for a good outcome. The dose of NTBC should be as low as possible without losing metabolic control. This has to be accompanied by a low protein diet, in some patients a simplified diet without calculation of protein intake. Specific education and psychosocial support are recommended. Indications for liver transplantation were defined. Monitoring shall include clinical findings, levels of SA, tyrosine, phenylalanine and NTBC in (dried) blood. | ||
| 650 | 4 | |a hepatorenal tyrosinaemia | |
| 650 | 4 | |a newborn screening | |
| 650 | 4 | |a nitisinone | |
| 650 | 4 | |a succinylacetone | |
| 650 | 4 | |a tyrosine | |
| 700 | 1 | |8 1\p |a Ballhausen, Diana |d 1972- |e VerfasserIn |0 (DE-588)123704936 |0 (DE-627)082718717 |0 (DE-576)293835632 |4 aut | |
| 700 | 1 | |a Haas, Dorothea |d 1965- |e VerfasserIn |0 (DE-588)1038104505 |0 (DE-627)756671280 |0 (DE-576)392125196 |4 aut | |
| 700 | 1 | |8 2\p |a Häberle, Johannes |d 1970- |e VerfasserIn |0 (DE-588)115472991 |0 (DE-627)691343098 |0 (DE-576)177118393 |4 aut | |
| 700 | 1 | |a Hagedorn, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Janson-Mutsaerts, Cecilia |e VerfasserIn |4 aut | |
| 700 | 1 | |8 3\p |a Janzen, Nils |d 1963- |e VerfasserIn |0 (DE-588)114348472 |0 (DE-627)602582490 |0 (DE-576)175668574 |4 aut | |
| 700 | 1 | |a Sander, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Freisinger, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karall, Daniela |e VerfasserIn |4 aut | |
| 700 | 1 | |8 4\p |a Meyer, Uta |e VerfasserIn |0 (DE-588)1060452146 |0 (DE-627)799925039 |0 (DE-576)416524710 |4 aut | |
| 700 | 1 | |8 5\p |a Mönch, Eberhard |d 1938- |e VerfasserIn |0 (DE-588)123549639 |0 (DE-627)082623333 |0 (DE-576)293761930 |4 aut | |
| 700 | 1 | |a Morlot, Susanne |e VerfasserIn |4 aut | |
| 700 | 1 | |8 6\p |a Rosenbaum-Fabian, Stefanie |e VerfasserIn |0 (DE-588)1165255286 |0 (DE-627)1029379254 |0 (DE-576)510329160 |4 aut | |
| 700 | 1 | |a Scholl-Bürgi, Sabine |e VerfasserIn |4 aut | |
| 700 | 1 | |8 7\p |a Vom Dahl, Stephan |d 1962- |e VerfasserIn |0 (DE-588)120356171 |0 (DE-627)080623484 |0 (DE-576)169797325 |4 aut | |
| 700 | 1 | |8 8\p |a Weinhold, Natalie |d 1970- |e VerfasserIn |0 (DE-588)124860567 |0 (DE-627)367227312 |0 (DE-576)187188610 |4 aut | |
| 700 | 1 | |a Zeman, Jiri |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lange, Karin |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of inherited metabolic disease |d Hoboken, NJ : Wiley, 1978 |g 48(2025), 1 vom: Jan., Artikel-ID e12824, Seite 1-18 |h Online-Ressource |w (DE-627)320457753 |w (DE-600)2006875-X |w (DE-576)105704652 |x 1573-2665 |7 nnas |a Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1 consensus group recommendations from the German-speaking countries |
| 773 | 1 | 8 | |g volume:48 |g year:2025 |g number:1 |g month:01 |g elocationid:e12824 |g pages:1-18 |g extent:18 |a Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1 consensus group recommendations from the German-speaking countries |
| 856 | 4 | 0 | |u https://doi.org/10.1002/jimd.12824 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12824 |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 4\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 5\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 6\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 7\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 8\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20250610 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1038104505 |a Haas, Dorothea |m 1038104505:Haas, Dorothea |d 910000 |d 910500 |d 50000 |e 910000PH1038104505 |e 910500PH1038104505 |e 50000PH1038104505 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1927850622 |e 4732816339 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Online veröffentlicht: 15. Dezember 2024","Gesehen am 10.06.2025"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"January 2025"}],"person":[{"family":"Das","given":"Anibh Martin","role":"aut","display":"Das, Anibh Martin"},{"family":"Ballhausen","given":"Diana","role":"aut","display":"Ballhausen, Diana"},{"role":"aut","display":"Haas, Dorothea","family":"Haas","given":"Dorothea"},{"role":"aut","display":"Häberle, Johannes","family":"Häberle","given":"Johannes"},{"display":"Hagedorn, Tobias","role":"aut","given":"Tobias","family":"Hagedorn"},{"family":"Janson-Mutsaerts","given":"Cecilia","display":"Janson-Mutsaerts, Cecilia","role":"aut"},{"family":"Janzen","given":"Nils","display":"Janzen, Nils","role":"aut"},{"given":"Johannes","family":"Sander","role":"aut","display":"Sander, Johannes"},{"given":"Peter","family":"Freisinger","display":"Freisinger, Peter","role":"aut"},{"family":"Karall","given":"Daniela","role":"aut","display":"Karall, Daniela"},{"family":"Meyer","given":"Uta","display":"Meyer, Uta","role":"aut"},{"display":"Mönch, Eberhard","role":"aut","given":"Eberhard","family":"Mönch"},{"role":"aut","display":"Morlot, Susanne","given":"Susanne","family":"Morlot"},{"family":"Rosenbaum-Fabian","given":"Stefanie","display":"Rosenbaum-Fabian, Stefanie","role":"aut"},{"display":"Scholl-Bürgi, Sabine","role":"aut","family":"Scholl-Bürgi","given":"Sabine"},{"display":"Vom Dahl, Stephan","role":"aut","given":"Stephan","family":"Vom Dahl"},{"given":"Natalie","family":"Weinhold","role":"aut","display":"Weinhold, Natalie"},{"given":"Jiri","family":"Zeman","display":"Zeman, Jiri","role":"aut"},{"given":"Karin","family":"Lange","display":"Lange, Karin","role":"aut"}],"physDesc":[{"extent":"18 S.","noteIll":"Illustrationen"}],"name":{"displayForm":["Anibh M. Das, Diana Ballhausen, Dorothea Haas, Johannes Häberle, Tobias Hagedorn, Cecilia Janson-Mutsaerts, Nils Janzen, Johannes Sander, Peter Freisinger, Daniela Karall, Uta Meyer, Eberhard Mönch, Susanne Morlot, Stefanie Rosenbaum-Fabian, Sabine Scholl-Bürgi, Stephan vom Dahl, Natalie Weinhold, Jiri Zeman, Karin Lange"]},"recId":"1927850622","id":{"doi":["10.1002/jimd.12824"],"eki":["1927850622"]},"title":[{"subtitle":"consensus group recommendations from the German-speaking countries","title_sort":"Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1","title":"Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1"}],"relHost":[{"pubHistory":["1.1978 -"],"id":{"issn":["1573-2665"],"eki":["320457753"],"zdb":["2006875-X"],"doi":["10.1002/(ISSN)1573-2665"]},"recId":"320457753","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 11.03.20","Ungezählte Beil.: Suppl"],"origin":[{"dateIssuedKey":"1978","publisherPlace":"Hoboken, NJ ; Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedDisp":"1978-","publisher":"Wiley ; Kluwer ; Springer Science + Business Media B.V"}],"disp":"Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1 consensus group recommendations from the German-speaking countriesJournal of inherited metabolic disease","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"JIMD"}],"language":["eng"],"title":[{"subtitle":"JIMD ; official journal of the Society for the Study of Inborn Errors of Metabolism","title":"Journal of inherited metabolic disease","title_sort":"Journal of inherited metabolic disease"}],"part":{"issue":"1","text":"48(2025), 1 vom: Jan., Artikel-ID e12824, Seite 1-18","pages":"1-18","extent":"18","year":"2025","volume":"48"}}],"titleAlt":[{"title":"Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type one"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a DASANIBHMADIAGNOSIST2025 | ||